 | • レポートコード：MRC2-11QY01555 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫調節剤のグローバル市場について調査・分析したレポートです。種類別（免疫抑制剤、免疫賦活剤）市場規模、用途別（腫瘍学、呼吸器、HIV、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫調節剤の競争状況、市場シェア ・世界の免疫調節剤市場：種類別市場規模 2015年-2020年（免疫抑制剤、免疫賦活剤） ・世界の免疫調節剤市場：種類別市場規模予測 2021年-2026年（免疫抑制剤、免疫賦活剤） ・世界の免疫調節剤市場：用途別市場規模 2015年-2020年（腫瘍学、呼吸器、HIV、その他） ・世界の免疫調節剤市場：用途別市場規模予測 2021年-2026年（腫瘍学、呼吸器、HIV、その他） ・北米の免疫調節剤市場分析：米国、カナダ ・ヨーロッパの免疫調節剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫調節剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫調節剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫調節剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Amgen Inc.、Abbott、Johnson & Johnson、Novartis AG、Eli Lilly and Company、Bristol-Myers Squibb Company、Merck & Co. Inc.、Biogen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Immunomodulators are referred to as the medications that are used for the regulation or for normalizing the immune system.
The global market for immunomodualtors is expected to grow exponentially over the forecast period owing to the rising cases of chronic diseases such as multiple sclerosis, allergic conditions, cancer, and asthma.
Market Analysis and Insights: Global Immunomodulators Market
The global Immunomodulators market size is projected to reach US$ 141150 million by 2026, from US$ 136630 million in 2020, at a CAGR of 3.1%% during 2021-2026.
Global Immunomodulators Scope and Market Size
Immunomodulators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunomodulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Immunomodulators market is segmented into
Immunosuppressant
Immunostimulants
Segment by Application, the Immunomodulators market is segmented into
Oncology
Respiratory
HIV
Others
Regional and Country-level Analysis
The Immunomodulators market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunomodulators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunomodulators Market Share Analysis
Immunomodulators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunomodulators business, the date to enter into the Immunomodulators market, Immunomodulators product introduction, recent developments, etc.
The major vendors covered:
Roche
Amgen Inc.
Abbott
Johnson & Johnson
Novartis AG
Eli Lilly and Company
Bristol-Myers Squibb Company
Merck & Co. Inc.
Biogen
1 Study Coverage
1.1 Immunomodulators Product Introduction
1.2 Market Segments
1.3 Key Immunomodulators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunomodulators Market Size Growth Rate by Type
1.4.2 Immunosuppressant
1.4.3 Immunostimulants
1.5 Market by Application
1.5.1 Global Immunomodulators Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Respiratory
1.5.4 HIV
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunomodulators Market Size, Estimates and Forecasts
2.1.1 Global Immunomodulators Revenue 2015-2026
2.1.2 Global Immunomodulators Sales 2015-2026
2.2 Global Immunomodulators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immunomodulators Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immunomodulators Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immunomodulators Competitor Landscape by Players
3.1 Immunomodulators Sales by Manufacturers
3.1.1 Immunomodulators Sales by Manufacturers (2015-2020)
3.1.2 Immunomodulators Sales Market Share by Manufacturers (2015-2020)
3.2 Immunomodulators Revenue by Manufacturers
3.2.1 Immunomodulators Revenue by Manufacturers (2015-2020)
3.2.2 Immunomodulators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunomodulators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunomodulators Revenue in 2019
3.2.5 Global Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immunomodulators Price by Manufacturers
3.4 Immunomodulators Manufacturing Base Distribution, Product Types
3.4.1 Immunomodulators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunomodulators Product Type
3.4.3 Date of International Manufacturers Enter into Immunomodulators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunomodulators Market Size by Type (2015-2020)
4.1.1 Global Immunomodulators Sales by Type (2015-2020)
4.1.2 Global Immunomodulators Revenue by Type (2015-2020)
4.1.3 Immunomodulators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunomodulators Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunomodulators Sales Forecast by Type (2021-2026)
4.2.2 Global Immunomodulators Revenue Forecast by Type (2021-2026)
4.2.3 Immunomodulators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunomodulators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunomodulators Market Size by Application (2015-2020)
5.1.1 Global Immunomodulators Sales by Application (2015-2020)
5.1.2 Global Immunomodulators Revenue by Application (2015-2020)
5.1.3 Immunomodulators Price by Application (2015-2020)
5.2 Immunomodulators Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunomodulators Sales Forecast by Application (2021-2026)
5.2.2 Global Immunomodulators Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunomodulators Price Forecast by Application (2021-2026)
6 North America
6.1 North America Immunomodulators by Country
6.1.1 North America Immunomodulators Sales by Country
6.1.2 North America Immunomodulators Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immunomodulators Market Facts & Figures by Type
6.3 North America Immunomodulators Market Facts & Figures by Application
7 Europe
7.1 Europe Immunomodulators by Country
7.1.1 Europe Immunomodulators Sales by Country
7.1.2 Europe Immunomodulators Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunomodulators Market Facts & Figures by Type
7.3 Europe Immunomodulators Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Immunomodulators by Region
8.1.1 Asia Pacific Immunomodulators Sales by Region
8.1.2 Asia Pacific Immunomodulators Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immunomodulators Market Facts & Figures by Type
8.3 Asia Pacific Immunomodulators Market Facts & Figures by Application
9 Latin America
9.1 Latin America Immunomodulators by Country
9.1.1 Latin America Immunomodulators Sales by Country
9.1.2 Latin America Immunomodulators Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immunomodulators Market Facts & Figures by Type
9.3 Central & South America Immunomodulators Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Immunomodulators by Country
10.1.1 Middle East and Africa Immunomodulators Sales by Country
10.1.2 Middle East and Africa Immunomodulators Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immunomodulators Market Facts & Figures by Type
10.3 Middle East and Africa Immunomodulators Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Immunomodulators Products Offered
11.1.5 Roche Related Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Description and Business Overview
11.2.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc. Immunomodulators Products Offered
11.2.5 Amgen Inc. Related Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Description and Business Overview
11.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbott Immunomodulators Products Offered
11.3.5 Abbott Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Immunomodulators Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Description and Business Overview
11.5.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis AG Immunomodulators Products Offered
11.5.5 Novartis AG Related Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Description and Business Overview
11.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly and Company Immunomodulators Products Offered
11.6.5 Eli Lilly and Company Related Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Corporation Information
11.7.2 Bristol-Myers Squibb Company Description and Business Overview
11.7.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Company Immunomodulators Products Offered
11.7.5 Bristol-Myers Squibb Company Related Developments
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Corporation Information
11.8.2 Merck & Co. Inc. Description and Business Overview
11.8.3 Merck & Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co. Inc. Immunomodulators Products Offered
11.8.5 Merck & Co. Inc. Related Developments
11.9 Biogen
11.9.1 Biogen Corporation Information
11.9.2 Biogen Description and Business Overview
11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen Immunomodulators Products Offered
11.9.5 Biogen Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Immunomodulators Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immunomodulators Market Estimates and Projections by Region
12.1.1 Global Immunomodulators Sales Forecast by Regions 2021-2026
12.1.2 Global Immunomodulators Revenue Forecast by Regions 2021-2026
12.2 North America Immunomodulators Market Size Forecast (2021-2026)
12.2.1 North America: Immunomodulators Sales Forecast (2021-2026)
12.2.2 North America: Immunomodulators Revenue Forecast (2021-2026)
12.2.3 North America: Immunomodulators Market Size Forecast by Country (2021-2026)
12.3 Europe Immunomodulators Market Size Forecast (2021-2026)
12.3.1 Europe: Immunomodulators Sales Forecast (2021-2026)
12.3.2 Europe: Immunomodulators Revenue Forecast (2021-2026)
12.3.3 Europe: Immunomodulators Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immunomodulators Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immunomodulators Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immunomodulators Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immunomodulators Market Size Forecast by Region (2021-2026)
12.5 Latin America Immunomodulators Market Size Forecast (2021-2026)
12.5.1 Latin America: Immunomodulators Sales Forecast (2021-2026)
12.5.2 Latin America: Immunomodulators Revenue Forecast (2021-2026)
12.5.3 Latin America: Immunomodulators Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immunomodulators Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immunomodulators Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immunomodulators Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immunomodulators Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunomodulators Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunomodulators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Immunomodulators Market Segments
Table 2. Ranking of Global Top Immunomodulators Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Immunomodulators Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Immunosuppressant
Table 5. Major Manufacturers of Immunostimulants
Table 6. Global Immunomodulators Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Immunomodulators Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Immunomodulators Sales by Regions 2015-2020 (K MT)
Table 9. Global Immunomodulators Sales Market Share by Regions (2015-2020)
Table 10. Global Immunomodulators Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Immunomodulators Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Immunomodulators Sales Share by Manufacturers (2015-2020)
Table 13. Global Immunomodulators Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Immunomodulators by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunomodulators as of 2019)
Table 15. Immunomodulators Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Immunomodulators Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Immunomodulators Price (2015-2020) (USD/MT)
Table 18. Immunomodulators Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Immunomodulators Product Type
Table 20. Date of International Manufacturers Enter into Immunomodulators Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Immunomodulators Sales by Type (2015-2020) (K MT)
Table 23. Global Immunomodulators Sales Share by Type (2015-2020)
Table 24. Global Immunomodulators Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Immunomodulators Revenue Share by Type (2015-2020)
Table 26. Immunomodulators Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Immunomodulators Sales by Application (2015-2020) (K MT)
Table 28. Global Immunomodulators Sales Share by Application (2015-2020)
Table 29. North America Immunomodulators Sales by Country (2015-2020) (K MT)
Table 30. North America Immunomodulators Sales Market Share by Country (2015-2020)
Table 31. North America Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Immunomodulators Revenue Market Share by Country (2015-2020)
Table 33. North America Immunomodulators Sales by Type (2015-2020) (K MT)
Table 34. North America Immunomodulators Sales Market Share by Type (2015-2020)
Table 35. North America Immunomodulators Sales by Application (2015-2020) (K MT)
Table 36. North America Immunomodulators Sales Market Share by Application (2015-2020)
Table 37. Europe Immunomodulators Sales by Country (2015-2020) (K MT)
Table 38. Europe Immunomodulators Sales Market Share by Country (2015-2020)
Table 39. Europe Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Immunomodulators Revenue Market Share by Country (2015-2020)
Table 41. Europe Immunomodulators Sales by Type (2015-2020) (K MT)
Table 42. Europe Immunomodulators Sales Market Share by Type (2015-2020)
Table 43. Europe Immunomodulators Sales by Application (2015-2020) (K MT)
Table 44. Europe Immunomodulators Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Immunomodulators Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Immunomodulators Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Immunomodulators Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Immunomodulators Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Immunomodulators Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Immunomodulators Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Immunomodulators Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Immunomodulators Sales Market Share by Application (2015-2020)
Table 53. Latin America Immunomodulators Sales by Country (2015-2020) (K MT)
Table 54. Latin America Immunomodulators Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Immunomodulators Revenue Market Share by Country (2015-2020)
Table 57. Latin America Immunomodulators Sales by Type (2015-2020) (K MT)
Table 58. Latin America Immunomodulators Sales Market Share by Type (2015-2020)
Table 59. Latin America Immunomodulators Sales by Application (2015-2020) (K MT)
Table 60. Latin America Immunomodulators Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Immunomodulators Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Immunomodulators Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Immunomodulators Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Immunomodulators Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Immunomodulators Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Immunomodulators Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Immunomodulators Sales Market Share by Application (2015-2020)
Table 69. Roche Corporation Information
Table 70. Roche Description and Major Businesses
Table 71. Roche Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Roche Product
Table 73. Roche Recent Development
Table 74. Amgen Inc. Corporation Information
Table 75. Amgen Inc. Description and Major Businesses
Table 76. Amgen Inc. Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Amgen Inc. Product
Table 78. Amgen Inc. Recent Development
Table 79. Abbott Corporation Information
Table 80. Abbott Description and Major Businesses
Table 81. Abbott Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Abbott Product
Table 83. Abbott Recent Development
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Major Businesses
Table 86. Johnson & Johnson Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Recent Development
Table 89. Novartis AG Corporation Information
Table 90. Novartis AG Description and Major Businesses
Table 91. Novartis AG Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Novartis AG Product
Table 93. Novartis AG Recent Development
Table 94. Eli Lilly and Company Corporation Information
Table 95. Eli Lilly and Company Description and Major Businesses
Table 96. Eli Lilly and Company Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Eli Lilly and Company Product
Table 98. Eli Lilly and Company Recent Development
Table 99. Bristol-Myers Squibb Company Corporation Information
Table 100. Bristol-Myers Squibb Company Description and Major Businesses
Table 101. Bristol-Myers Squibb Company Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Company Product
Table 103. Bristol-Myers Squibb Company Recent Development
Table 104. Merck & Co. Inc. Corporation Information
Table 105. Merck & Co. Inc. Description and Major Businesses
Table 106. Merck & Co. Inc. Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Merck & Co. Inc. Product
Table 108. Merck & Co. Inc. Recent Development
Table 109. Biogen Corporation Information
Table 110. Biogen Description and Major Businesses
Table 111. Biogen Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Biogen Product
Table 113. Biogen Recent Development
Table 114. Global Immunomodulators Sales Forecast by Regions (2021-2026) (K MT)
Table 115. Global Immunomodulators Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Immunomodulators Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Immunomodulators Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Immunomodulators Sales Forecast by Country (2021-2026) (K MT)
Table 119. North America: Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Immunomodulators Sales Forecast by Country (2021-2026) (K MT)
Table 121. Europe: Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Immunomodulators Sales Forecast by Region (2021-2026) (K MT)
Table 123. Asia Pacific: Immunomodulators Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Immunomodulators Sales Forecast by Country (2021-2026) (K MT)
Table 125. Latin America: Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Immunomodulators Sales Forecast by Country (2021-2026) (K MT)
Table 127. Middle East and Africa: Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Immunomodulators Players
Table 132. Immunomodulators Customers List
Table 133. Immunomodulators Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunomodulators Product Picture
Figure 2. Global Immunomodulators Sales Market Share by Type in 2020 & 2026
Figure 3. Immunosuppressant Product Picture
Figure 4. Immunostimulants Product Picture
Figure 5. Global Immunomodulators Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Respiratory
Figure 8. HIV
Figure 9. Others
Figure 10. Immunomodulators Report Years Considered
Figure 11. Global Immunomodulators Market Size 2015-2026 (US$ Million)
Figure 12. Global Immunomodulators Sales 2015-2026 (K MT)
Figure 13. Global Immunomodulators Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Immunomodulators Sales Market Share by Region (2015-2020)
Figure 15. Global Immunomodulators Sales Market Share by Region in 2019
Figure 16. Global Immunomodulators Revenue Market Share by Region (2015-2020)
Figure 17. Global Immunomodulators Revenue Market Share by Region in 2019
Figure 18. Global Immunomodulators Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Immunomodulators Revenue in 2019
Figure 20. Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Immunomodulators Sales Market Share by Type (2015-2020)
Figure 22. Global Immunomodulators Sales Market Share by Type in 2019
Figure 23. Global Immunomodulators Revenue Market Share by Type (2015-2020)
Figure 24. Global Immunomodulators Revenue Market Share by Type in 2019
Figure 25. Global Immunomodulators Market Share by Price Range (2015-2020)
Figure 26. Global Immunomodulators Sales Market Share by Application (2015-2020)
Figure 27. Global Immunomodulators Sales Market Share by Application in 2019
Figure 28. Global Immunomodulators Revenue Market Share by Application (2015-2020)
Figure 29. Global Immunomodulators Revenue Market Share by Application in 2019
Figure 30. North America Immunomodulators Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Immunomodulators Sales Market Share by Country in 2019
Figure 33. North America Immunomodulators Revenue Market Share by Country in 2019
Figure 34. U.S. Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Immunomodulators Market Share by Type in 2019
Figure 39. North America Immunomodulators Market Share by Application in 2019
Figure 40. Europe Immunomodulators Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Immunomodulators Sales Market Share by Country in 2019
Figure 43. Europe Immunomodulators Revenue Market Share by Country in 2019
Figure 44. Germany Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Immunomodulators Market Share by Type in 2019
Figure 55. Europe Immunomodulators Market Share by Application in 2019
Figure 56. Asia Pacific Immunomodulators Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Immunomodulators Sales Market Share by Region in 2019
Figure 59. Asia Pacific Immunomodulators Revenue Market Share by Region in 2019
Figure 60. China Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Immunomodulators Market Share by Type in 2019
Figure 83. Asia Pacific Immunomodulators Market Share by Application in 2019
Figure 84. Latin America Immunomodulators Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Immunomodulators Sales Market Share by Country in 2019
Figure 87. Latin America Immunomodulators Revenue Market Share by Country in 2019
Figure 88. Mexico Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Immunomodulators Market Share by Type in 2019
Figure 95. Latin America Immunomodulators Market Share by Application in 2019
Figure 96. Middle East and Africa Immunomodulators Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Immunomodulators Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Immunomodulators Revenue Market Share by Country in 2019
Figure 100. Turkey Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Immunomodulators Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Immunomodulators Market Share by Type in 2019
Figure 107. Middle East and Africa Immunomodulators Market Share by Application in 2019
Figure 108. North America Immunomodulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Immunomodulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Immunomodulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Immunomodulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Immunomodulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
自己免疫・炎症性免疫調節剤の世界市場（～2026年） Market Analysis and Insights: Global Autoimmune and Inflammatory Immunomodulators Market The global Autoimmune and Inflammatory Immunomodulators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autoimmune and Inflammato…- 牛呼吸器疾患治療の世界市場（～2026年） Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, enviro…
- 免疫抑制薬の世界市場（～2026年） Market Analysis and Insights: Global Immunosuppressant Drugs Market The global Immunosuppressant Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Immunosuppressant Drugs Scope and Market Size Immunosuppressant Dru…
- 皮膚肥満細胞症の世界市場（～2026年） Mastocytosis is rare condition characterized by excessive accumulation of mast cells in the body tissues. Mast cells release large amounts of histamine in blood which leads to itchy skin, skin rash and hot flushes. These cells are found in skin and the lining of stomach and lungs. Mast cells accumul…
- ヒトパピローマウイルス（HPV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Papillomaviru Therapeutics Market The global Human Papillomaviru Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomaviru Therapeutics Scope and Market…